Helping Alaska Native people quit smoking using personalized care.
Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking
['FUNDING_OTHER'] · SOUTHCENTRAL FOUNDATION · NIH-10923997
This study is creating a special program to help Alaska Native and American Indian people quit smoking by using a unique test to tailor the treatment just for them, and we want to see how well this personalized approach works for those trying to quit.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SOUTHCENTRAL FOUNDATION (nih funded) |
| Locations | 1 site (ANCHORAGE, UNITED STATES) |
| Trial ID | NIH-10923997 on ClinicalTrials.gov |
What this research studies
This research aims to develop a tailored smoking cessation program specifically for Alaska Native and American Indian individuals, who have higher smoking rates compared to other populations. The project will explore the use of a biomarker called nicotine metabolite ratio to personalize treatment options, potentially improving the effectiveness of smoking cessation methods. By assessing the acceptability and feasibility of this approach, the research seeks to enhance existing strategies that have not significantly reduced smoking rates in this community. Participants will be involved in evaluating how well this personalized care can help them quit smoking.
Who could benefit from this research
Good fit: Ideal candidates for this research are Alaska Native and American Indian individuals aged 21 and older who are seeking to quit smoking.
Not a fit: Patients who are not Alaska Native or American Indian, or those who do not smoke, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective smoking cessation treatments for Alaska Native people, ultimately reducing smoking-related health issues.
How similar studies have performed: Previous research has shown promise in using genetically informed biomarkers for smoking cessation in other populations, indicating potential for success in this novel approach.
Where this research is happening
ANCHORAGE, UNITED STATES
- SOUTHCENTRAL FOUNDATION — ANCHORAGE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MICHLIG, GEORGIA J — SOUTHCENTRAL FOUNDATION
- Study coordinator: MICHLIG, GEORGIA J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.